This publication is protected and can be accessed only from certain IPs.
This publication is protected and can be accessed only from certain IPs.

Title: New 2-aminoimidazolone derivatives as adjuvants able to inhibit mechanisms of bacterial and cancer multidrug resistance


Multidrug resistance (MDR) is a global problem in the treatment of bacterial infections and cancer. One of the solutions is to search for adjuvants able to block at least one of the mechanisms of resistance. Research performed within this PhD-thesis included design, synthesis, biological as well as “drug-like” properties evaluation of the 2-aminoimidazolone derivatives as potential adjuvants in the treatment of bacterial infections and cancer. Design of new compounds was conducted on the basis of previously found active compounds. A series of 49 new imidazolones was synthesized in 3-6- stages. The obtained compounds were tested for their antibiotic adjuvant activity in Gram positive and Gram negative bacterial strains, while determination of their adjuvant activity in chemotherapy was performed in T-lymphoma cancer cells. An attempt to assess mechanisms of imidazolones` action was taken using both, in silico and in vitro assays. For selected imidazolones, ADMETox and physicochemical assays were carried out. Finally, structureactivity relationship (SAR) studies were conducted. This research indicated that 2-aminoimidazolones displayed potency of adjuvants for the treatment of multidrug resistant bacterial infections and cancer.

Place of publishing:


Level of degree:

2 - studia doktoranckie

Degree grantor:

Wydział Farmaceutyczny


Handzlik, Jadwiga

Date issued:




Call number:



pol; eng

Access rights:

tylko w bibliotece

Object collections:

Last modified:

May 23, 2022

In our library since:

Mar 31, 2022

Number of object content hits:


Number of object content views in PDF format


All available object's versions:


Show description in RDF format:


Show description in OAI-PMH format:


Edition name Date
ZB-134219 May 23, 2022


Citation style:

This page uses 'cookies'. More information